These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
166 related items for PubMed ID: 11488935
1. Platelet-derived growth factor (PDGF) in human acute myelogenous leukemia: PDGF receptor expression, endogenous PDGF release and responsiveness to exogenous PDGF isoforms by in vitro cultured acute myelogenous leukemia blasts. Foss B, Ulvestad E, Bruserud O. Eur J Haematol; 2001 Jun; 66(6):365-76. PubMed ID: 11488935 [Abstract] [Full Text] [Related]
2. Platelet-derived growth factor (PDGF) in human acute myelogenous leukemia: PDGF receptor expression, endogenous PDGF release and responsiveness to exogenous PDGF isoforms by in vitro cultured acute myelogenous leukemia blasts. Foss B, Ulvestad E, Bruserud Ø. Eur J Haematol; 2001 Oct; 67(4):267-78. PubMed ID: 11860452 [Abstract] [Full Text] [Related]
4. Leptin in human acute myelogenous leukemia: studies of in vivo levels and in vitro effects on native functional leukemia blasts. Bruserud Ø, Huang TS, Glenjen N, Gjertsen BT, Foss B. Haematologica; 2002 Jun; 87(6):584-95. PubMed ID: 12031914 [Abstract] [Full Text] [Related]
5. Effects of acute myelogenous leukemia blasts on platelet release of soluble P-selectin and platelet-derived growth factor. Bruserud Ø, Foss B, Ulvestad E, Hervig T. Platelets; 1998 Jun; 9(6):352-8. PubMed ID: 16793718 [Abstract] [Full Text] [Related]
6. Effects of endogenous interleukin 1 on blast cells derived from acute myelogenous leukemia patients. Bruserud O. Leuk Res; 1996 Jan; 20(1):65-73. PubMed ID: 8632679 [Abstract] [Full Text] [Related]
7. Effects of interleukin-13 on cytokine secretion by human acute myelogenous leukemia blasts. Bruserud O. Leukemia; 1996 Sep; 10(9):1497-1503. PubMed ID: 8751469 [Abstract] [Full Text] [Related]
14. In vitro effects of insulin-like growth factor-1 (IGF-1) on proliferation and constitutive cytokine secretion by acute myelogenous leukemia blasts. Frostad S, Bruserud O. Eur J Haematol; 1999 Mar; 62(3):191-8. PubMed ID: 10089897 [Abstract] [Full Text] [Related]
15. Platelet-derived growth factor expression in accelerated and blastic phase of chronic myelogenous leukaemia with myelofibrosis. Kimura A, Nakata Y, Hyodo H, Kuramoto A, Satow Y. Br J Haematol; 1994 Feb; 86(2):303-7. PubMed ID: 8199019 [Abstract] [Full Text] [Related]
16. Subclassification of patients with acute myelogenous leukemia based on chemokine responsiveness and constitutive chemokine release by their leukemic cells. Bruserud Ø, Ryningen A, Olsnes AM, Stordrange L, Øyan AM, Kalland KH, Gjertsen BT. Haematologica; 2007 Mar; 92(3):332-41. PubMed ID: 17339182 [Abstract] [Full Text] [Related]
17. IL-4, IL-10 and IL-13 in acute myelogenous leukemia. Bruserud O. Cytokines Cell Mol Ther; 1998 Sep; 4(3):187-98. PubMed ID: 9825844 [Abstract] [Full Text] [Related]